Thanks to the advances in technology over the past few years, there has been an ongoing and in-depth study of the genes that make up the human being as a whole and more specifically those involved in pathologies and diseases affecting the general population. So far, over 50 different vitiligo susceptible genes have been identified [1–3]. Gaining a better understanding of the genes involved in vitiligo may in the future lead to a better approach in treating vitiligo and might even allow for disease prevention in genetically susceptible individuals.
- 2.Shen C, Gao J, Sheng Y, Dou J, Zhou F, Zheng X, Ko R, Tang X, Zhu C, Yin X, Sun L, Cui Y, Zhang X. Genetic susceptibility to vitiligo: GWAS approaches for identifying vitiligo susceptibility genes and loci. Front Genet. 2016;7:3. https://doi.org/10.3389/fgene.2016.00003.
- 6.Schallreuter KU, Moore J, Wood JM, Beazley WD, Gaze DC, Tobin DJ, Marshall HS, Panske A, Panzig E, Hibberts NA. In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J Investig Dermatol Symp Proc. 1999;4(1):91–6.CrossRefGoogle Scholar
- 11.Harris JE, Harris TH, Weninger W, Wherry EJ, Hunter CA, Turka LA. A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8+ T-cell accumulation in the skin. J Invest Dermatol. 2012;132(7):1869–76. https://doi.org/10.1038/jid.2011.463.CrossRefPubMedPubMedCentralGoogle Scholar
- 14.Becatti M, Prignano F, Fiorillo C, Pescitelli L, Nassi P, Lotti T, Taddei N. The involvement of Smac/DIABLO, p53, NF-kB, and MAPK pathways in apoptosis of keratinocytes from perilesional vitiligo skin: protective effects of curcumin and capsaicin. Antioxid Redox Signal. 2010;13(9):1309–21. https://doi.org/10.1089/ars.2009.2779.CrossRefPubMedGoogle Scholar
- 15.Shi F, Kong BW, Song JJ, Lee JY, Dienglewicz RL, Erf GF. Understanding mechanisms of vitiligo development in Smyth line of chickens by transcriptomic microarray analysis of evolving autoimmune lesions. BMC Immunol. 2012;13:18. https://doi.org/10.1186/1471-2172-13-18.CrossRefPubMedPubMedCentralGoogle Scholar
- 16.Rashighi M, Agarwal P, Richmond JM, Harris TH, Dresser K, Su MW, Zhou Y, Deng A, Hunter CA, Luster AD, Harris JE. CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo. Sci Transl Med. 2014;6(223):223ra23. https://doi.org/10.1126/scitranslmed.3007811.CrossRefPubMedPubMedCentralGoogle Scholar
- 17.Eby JM, Kang HK, Klarquist J, Chatterjee S, Mosenson JA, Nishimura MI, Garrett-Mayer E, Longley BJ, Engelhard VH, Mehrotra S, Le Poole IC. Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation. Pigment Cell Melanoma Res. 2014;27(6):1075–85. https://doi.org/10.1111/pcmr.12284.CrossRefPubMedPubMedCentralGoogle Scholar